Precision-Panc Team Opens PRIMUS-006 Study For Gemcitabine, Pembrolizumab
18 Jun 2024 //
GLOBENEWSWIRE
Immodulon to Participate in the Wells Fargo Virtual Private Biotech Symposium
29 Apr 2024 //
GLOBENEWSWIRE
Immodulon Announces Formation of New Scientific Advisory Board
11 Dec 2023 //
GLOBENEWSWIRE
Immodulon Appoints Richard Couch as CTO and Owen Vaughan as CRO
26 Jun 2023 //
GLOBENEWSWIRE
Immodulon, Champalimaud Foundation team up on ‘difficult to treat’ cancers
04 Aug 2020 //
PHARMATIMES